Daily Archives: April 16, 2019 | LinksMedicus Free Medical News & Perspectives

Tue April 16 – 10 Stories of The Day!

16 Apr, 2019 | 02:56h | UTC

1 – Measles cases are up nearly 300% from last year. This is a global crisis – CNN (free)

WHO Statement: New measles surveillance data for 2019 – World Health Organization (free)

By Henrietta H Fore (executive director of UNICEF) and Tedros Adhanom Ghebreyesus (director general of the World Health Organization).

2 – Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy – New England Journal of Medicine (free for a limited period)

Commentary: Canagliflozin may offer renal protection in people with type 2 diabetes and CKD – Medicine Matters (free)

“among 1000 patients treated for 2.5 years, 21.2 individuals would need to be treated to prevent the composite primary outcome.” (from Medicine Matters)

3 – Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): A multicenter, randomized, placebo controlled trial – Arthritis & Rheumatology (free)

Commentaries: Statins safe for rheumatoid arthritis patients – University of Dundee (free) AND Statins safe for preventing cardiovascular events in rheumatoid arthritis patients, study suggests – Wiley (free)

4 – Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health – Circulation (free PDF)

Commentaries: FDA added sugar label could be a cost-effective way to improve health, generate savings – Tufts University (free) AND New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings – TCTMD (free) AND Study: Sugar-added labels could prevent 600,000 diabetes cases – UPI (free) AND New ‘added sugars’ labeling could save money and improve health – Reuters (free)

5 – Alex Nowbar’s research reviews, 15 April 2019 – The BMJ Opinion (free)

6 – Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States – JAMA Oncology (free for a limited period)

Commentary: One-third of cancer patients use complementary and alternative medicine – UT Southwestern Medical Center (free) AND How Many Cancer Patients Use Complementary or Alternative Medicine Treatments? – MedicalResearch.com (free) AND Many cancer patients take alternative meds but don’t tell doctors – UPI (free)

Related: Use of Alternative Medicine for Cancer and Its Impact on Survival (free study and commentaries)

7 – Natural History of Spontaneous Coronary Artery Dissection With Spontaneous Angiographic Healing – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)

Commentaries: Majority of SCAD Lesions Heal With Conservative Treatment – TCTMD (free) AND Spontaneous Angiographic Healing With SCAD – American College of Cardiology (free) AND SCAD: Spontaneous Healing Common With Conservative Treatment – Medscape (free registration required)

8 – Spontaneous coronary artery dissection: An often unrecognized cause of acute coronary syndrome – Cleveland Clinic Journal of Medicine (free)

9 – Acute Renal Failure of Nosocomial Origin – Deutsches Ärzteblatt international (free)

10 – Gestational diabetes associated with incident diabetes in childhood and youth: a retrospective cohort study – Canadian Medical Association Journal (free)

Commentary: Maternal gestational diabetes linked to diabetes in children – CMAJ (free)

Randomized Trial: SGLT2 inhibitor Reduces Progression of Kidney Disease in Patients with Type 2 Diabetes and Nephropathy

16 Apr, 2019 | 02:52h | UTC

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy – New England Journal of Medicine (free for a limited period)

Commentary: Canagliflozin may offer renal protection in people with type 2 diabetes and CKD – Medicine Matters (free)

“among 1000 patients treated for 2.5 years, 21.2 individuals would need to be treated to prevent the composite primary outcome.” (from Medicine Matters)